Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team
NCT05319561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2026-05-01
Summary
Antimicrobial-resistant and healthcare-associated pathogens are a global health threat. The goals of antimicrobial stewardship are to minimize unnecessary and inappropriate antimicrobial use as a means to combat antimicrobial resistance. Previously, the investigators implemented a Videoconference Antimicrobial Stewardship Team (VAST) at 2 VA Medical Centers (VAMCs), using telehealth to connect clinicians at a rural VAMC to a geographically distant infectious disease expert Both VASTs successfully decreased overall antibiotic use in acute and long-term care units. This project will expand the VAST approach to other VAMCs and test the hypothesis that quarterly reports that quantify facility-level antibiotic use will enhance the efficacy of VASTs to support antimicrobial stewardship. This work will directly increase access to antimicrobial stewardship consultation at rural VA facilities, which are often underserved by infectious disease expertise.
Conditions
- Common Infections
- Urinary Tract Infections
- Pneumonia
Interventions
- OTHER
-
Antibiotic Use Report
The Antibiotic Use Report uses both text and graphics to communicate successes and improvement opportunities specific to the VAMC for which it is prepared. The graphs summarize overall antibiotic use over the previous year, with additional information regarding use of broad- and narrow-spectrum agents. Further, each Antibiotic Use Report compares or "benchmarks" the individual VAMC for which it is prepared to other VAMCs in the same Medical Complexity Group. This approach adapts and expands peer comparison, which has proven effective at reducing inappropriate antibiotic use in outpatient settings.
Sponsors & Collaborators
-
VA Office of Research and Development
lead FED
Principal Investigators
-
Robin Lynn Paige Jump, MD PhD · VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
-
Charlesnika Tyon Evans, PhD MPH BS · Edward Hines Jr. VA Hospital, Hines, IL
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-28
- Primary Completion
- 2025-03-31
- Completion
- 2026-03-31
Countries
- United States
Study Locations
More Related Trials
-
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
NCT04218799 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Antibiotics on Urinary Microbiome
NCT04230746 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
NCT01292031 ·Status: COMPLETED ·Phase: PHASE3
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record
NCT03397433 ·Status: COMPLETED ·Phase: NA
-
Predictors of Rates of Resistant Gram-Negative Bacteria
NCT01075009 ·Status: COMPLETED
-
Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)
NCT05743192 ·Status: COMPLETED
-
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
NCT02683603 ·Status: COMPLETED ·Phase: PHASE4
-
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
NCT04793152 ·Status: RECRUITING ·Phase: NA
-
Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
NCT00167986 ·Status: COMPLETED
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Vancomycin De-escalation Therapy in Patients With Pneumonia
NCT03586362 ·Status: UNKNOWN
-
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
NCT06069206 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
NCT00862862 ·Status: TERMINATED
-
Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis
NCT03012360 ·Status: TERMINATED ·Phase: PHASE4
-
Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit
NCT05171257 ·Status: COMPLETED
-
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370 ·Status: COMPLETED ·Phase: NA
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA
-
Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.
NCT03007290 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
NCT01055106 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Perioperative S. Aureus Transmission Via OR PathTrac
NCT04657185 ·Status: COMPLETED
-
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
NCT05726318 ·Status: COMPLETED ·Phase: PHASE4
-
Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
NCT05199324 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
NCT02443064 ·Status: UNKNOWN ·Phase: PHASE4